Biomolecules (Apr 2019)

Regulation of the Expression of DAPK1 by SUMO Pathway

  • Qingshui Wang,
  • Xiuli Zhang,
  • Ling Chen,
  • Shuyun Weng,
  • Yun Xia,
  • Yan Ye,
  • Ke Li,
  • Ziqiang Liao,
  • Pengchen Chen,
  • Khaldoon Alsamman,
  • Chen Meng,
  • Craig Stevens,
  • Ted R. Hupp,
  • Yao Lin

DOI
https://doi.org/10.3390/biom9040151
Journal volume & issue
Vol. 9, no. 4
p. 151

Abstract

Read online

Death Associated Protein Kinase 1 (DAPK1) is an important signaling kinase mediating the biological effect of multiple natural biomolecules such as IFN-γ, TNF-α, curcumin, etc. DAPK1 is degraded through both ubiquitin-proteasomal and lysosomal degradation pathways. To investigate the crosstalk between these two DAPK1 degradation pathways, we carried out a screen using a set of ubiquitin E2 siRNAs at the presence of Tuberous Sclerous 2 (TSC2) and identified that the small ubiquitin-like molecule (SUMO) pathway is able to regulate the protein levels of DAPK1. Inhibition of the SUMO pathway enhanced DAPK1 protein levels and the minimum domain of DAPK1 protein required for this regulation is the kinase domain, suggesting that the SUMO pathway regulates DAPK1 protein levels independent of TSC2. Suppression of the SUMO pathway did not enhance DAPK1 protein stability. In addition, mutation of the potential SUMO conjugation sites on DAPK1 kinase domain did not alter its protein stability or response to SUMO pathway inhibition. These data suggested that the SUMO pathway does not regulate DAPK1 protein degradation. The exact molecular mechanism underlying this regulation is yet to be discovered.

Keywords